Title:
腫瘍抗原を発現するポックスウイルス及びＴＩＭ－３に対するモノクローナル抗体を用いた癌治療のための併用療法
Document Type and Number:
Japanese Patent JP7368305
Kind Code:
B2
Abstract:
The invention relates to compositions, kits, and methods for cancer therapy using recombinant poxviruses encoding a tumor-associated antigen in combination with a monoclonal antibody against immune checkpoint molecule TIM-3.
Inventors:
Foy Susan
Mandle Stephanie
Roundley Liang
Mandle Stephanie
Roundley Liang
Application Number:
JP2020072789A
Publication Date:
October 24, 2023
Filing Date:
April 15, 2020
Export Citation:
Assignee:
Bavarian Nordic Actiselskab
International Classes:
A61K39/275; A61K39/00; A61K39/395; A61P35/00; A61P43/00
Domestic Patent References:
| JP2007530560A |
Foreign References:
| WO2013190555A1 | ||||
| WO2014062778A1 |
Other References:
Journal for ImmunoTherapy of Cancer,2013,Vol.1,Suppl.1,P72
Frontiers in Immunology,2013,Vol.4,Article449,p.1-7
Trends in Immunology,2011,VOL.32,No.8,p.345-349
Frontiers in Immunology,2013,Vol.4,Article449,p.1-7
Trends in Immunology,2011,VOL.32,No.8,p.345-349
Attorney, Agent or Firm:
Mitsufumi Ezaki
Blacksmith Minoru Sawa
Katsuri Uenishi
Ichiro Torayama
Taisei Ishida
Blacksmith Minoru Sawa
Katsuri Uenishi
Ichiro Torayama
Taisei Ishida